(+-)-6-Propyl-4,5,6,7-tetrahydro-5-methylimidazo(4,5,1-jk)(1,4)benzodiazepin-2(1H)-one | 131514-90-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯二氮卓类
• 英文名称: (+-)-6-Propyl-4,5,6,7-tetrahydro-5-methylimidazo(4,5,1-jk)(1,4)benzodiazepin-2(1H)-one
• 英文别名: 11-methyl-10-propyl-1,3,10-triazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-trien-2-one
• CAS: 131514-90-4
• 化学式: C₁₄H₁₉N₃O
• 分子量: 245.324
• InChiKey: RMWFDGMVDKRISB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  35.6
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (+-)-6-Propyl-4,5,6,7-tetrahydro-5-methylimidazo(4,5,1-jk)(1,4)benzodiazepin-2(1H)-one 在 sodium carbonate 、 三氯氧磷 作用下， 生成 1-Chloro-8-methyl-7-propyl-6,7,8,9-tetrahydro-2,7,9a-triaza-benzo[cd]azulene
  参考文献：
  名称：

  4,5,6,7-四氢-5-甲基咪唑并[4,5,1-jk] [1,4]苯并二氮杂-2-2（1H）-on e（TIBO）衍生物的合成及抗HIV-1活性。2。

  摘要：

  在该系列的第一篇论文中，揭示了一种具有抗HIV-1活性的新结构，并合成了类似物以探讨9位N-6位上连接的取代基（R）的变化与构效关系。描述了具有4,5,6,7-四氢-5-甲基咪唑[4,5,1-jk] [1,4]的五元脲环变异的类似物的合成和抗HIV-1测试苯并二氮杂-2-2（1H）-一（TIBO）结构。尽管合成了许多不同的环来取代TIBO的环状脲，但发现大多数环在抑制MT-1细胞中HIV-1病毒的复制方面没有活性。例外是用硫或硒代替尿素氧，得到相应的硫脲或硒脲。发现它们比氧气对应物更具活性。合成并测试了一小部分类似物，可以直接比较尿素和硫脲衍生物。毫无例外，后者总是比前者更加活跃。发现该系列（8d）中活性最高的化合物抑制HIV-1病毒，其IC50为0.012 microM，与AZT相当。

  DOI：

  10.1021/jm00115a007
• 作为产物：
  描述：

  2-溴-3-硝基苯甲酸甲酯 在 palladium on activated charcoal 2-羟基吡啶 、 lithium aluminium tetrahydride 、 硫酸 、 氢气 、 sodium carbonate 、 potassium iodide 作用下， 以 四氢呋喃 、 溶剂黄146 、 N,N-二甲基甲酰胺 、 xylene 、 正丁醇 为溶剂， 42.0 ℃ 、413.69 kPa 条件下， 反应 74.17h， 生成 (+-)-6-Propyl-4,5,6,7-tetrahydro-5-methylimidazo(4,5,1-jk)(1,4)benzodiazepin-2(1H)-one
  参考文献：
  名称：

  Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives

  摘要：

  A series of 6-substituted 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones (9) have been synthesized and tested for their ability to inhibit the replication of the HIV-1 virus in MT-4 cells. Two synthetic methods are described, one of which allows the synthesis of single enantiomers of the final products. A structure-activity study was done within the series of compounds to determine the optimum group for the 6-position substitution and to determine whether the activity was enantiospecific at the 5-position, which was substituted with a methyl group. The best analogue, 9jj, inhibited HIV-1 with an IC50 of 4-mu-M, which is comparable to the activity level of DDI, a 2',3'-dideoxynucleoside-type structure undergoing clinical trials as an anti-AIDS therapy.

  DOI：

  10.1021/jm00106a040

文献信息

• Antiviral tetrahydroimidazo (1,4) benzodiazepin-2-ones
  申请人：JANSSEN PHARMACEUTICA N.V.

  公开号：EP0336466B1

  公开（公告）日：1992-12-30
• Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives
  作者：Michael J. Kukla、Henry J. Breslin、Rudi Pauwels、Cynthia L. Fedde、Milton Miranda、Malcolm K. Scott、Ronald G. Sherrill、Alfons Raeymaekers、Jozef Van Gelder

  DOI：10.1021/jm00106a040

  日期：1991.2

  A series of 6-substituted 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones (9) have been synthesized and tested for their ability to inhibit the replication of the HIV-1 virus in MT-4 cells. Two synthetic methods are described, one of which allows the synthesis of single enantiomers of the final products. A structure-activity study was done within the series of compounds to determine the optimum group for the 6-position substitution and to determine whether the activity was enantiospecific at the 5-position, which was substituted with a methyl group. The best analogue, 9jj, inhibited HIV-1 with an IC50 of 4-mu-M, which is comparable to the activity level of DDI, a 2',3'-dideoxynucleoside-type structure undergoing clinical trials as an anti-AIDS therapy.
• Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2
  作者：Michael J. Kukla、Henry J. Breslin、Craig J. Diamond、Philip P. Grous、Chih Y. Ho、Milton Miranda、James D. Rodgers、Ronald G. Sherrill、Erik De Clercq、Rudi Pauwels、Koen Andries、Luc J. Moens、Marcel A. C. Janssen、Paul A. J. Janssen

  DOI：10.1021/jm00115a007

  日期：1991.11.1

  substituent (R) attached at the N-6 position of 9. This study describes the syntheses and anti-HIV-1 testing of analogues with variations of the five-membered urea ring of the 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)-one (TIBO) structures. Although many different rings were synthesized to replace the cyclic urea of TIBO, most were found to be inactive in inhibiting the replication

  在该系列的第一篇论文中，揭示了一种具有抗HIV-1活性的新结构，并合成了类似物以探讨9位N-6位上连接的取代基（R）的变化与构效关系。描述了具有4,5,6,7-四氢-5-甲基咪唑[4,5,1-jk] [1,4]的五元脲环变异的类似物的合成和抗HIV-1测试苯并二氮杂-2-2（1H）-一（TIBO）结构。尽管合成了许多不同的环来取代TIBO的环状脲，但发现大多数环在抑制MT-1细胞中HIV-1病毒的复制方面没有活性。例外是用硫或硒代替尿素氧，得到相应的硫脲或硒脲。发现它们比氧气对应物更具活性。合成并测试了一小部分类似物，可以直接比较尿素和硫脲衍生物。毫无例外，后者总是比前者更加活跃。发现该系列（8d）中活性最高的化合物抑制HIV-1病毒，其IC50为0.012 microM，与AZT相当。